Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Mårtensson E[au]:

Search results

Items: 1 to 50 of 69

1.

Nanoshells prepared by atomic layer deposition - Long acting depots of indomethacin.

Hellrup J, Rooth M, Mårtensson E, Sigfridsson K, Johansson A.

Eur J Pharm Biopharm. 2019 Jul;140:60-66. doi: 10.1016/j.ejpb.2019.04.019. Epub 2019 May 2.

PMID:
31055064
2.

Simultaneous Growth of Pure Wurtzite and Zinc Blende Nanowires.

Lehmann S, Wallentin J, Mårtensson EK, Ek M, Deppert K, Dick KA, Borgström MT.

Nano Lett. 2019 Apr 10;19(4):2723-2730. doi: 10.1021/acs.nanolett.9b01007. Epub 2019 Mar 26.

PMID:
30888174
3.

Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro.

Keemink J, Mårtensson E, Bergström CAS.

Mol Pharm. 2019 Mar 4;16(3):921-930. doi: 10.1021/acs.molpharmaceut.8b00811. Epub 2019 Jan 29.

4.

Simulation of GaAs Nanowire Growth and Crystal Structure.

Mårtensson EK, Lehmann S, Dick KA, Johansson J.

Nano Lett. 2019 Feb 13;19(2):1197-1203. doi: 10.1021/acs.nanolett.8b04637. Epub 2019 Jan 10.

PMID:
30618259
5.

Biallelic germline nonsense variant of MLH3 underlies polyposis predisposition.

Olkinuora A, Nieminen TT, Mårtensson E, Rohlin A, Ristimäki A, Koskenvuo L, Lepistö A; Swedish Extended Genetic Analysis of Colorectal Neoplasia (SWEN) Study Group, Gebre-Medhin S, Nordling M, Peltomäki P.

Genet Med. 2018 Dec 21. doi: 10.1038/s41436-018-0405-x. [Epub ahead of print]

PMID:
30573798
6.

PREPL deficiency: delineation of the phenotype and development of a functional blood assay.

Régal L, Mårtensson E, Maystadt I, Voermans N, Lederer D, Burlina A, Juan Fita MJ, Hoogeboom AJM, Olsson Engman M, Hollemans T, Schouten M, Meulemans S, Jonson T, François I, Gil Ortega D, Kamsteeg EJ, Creemers JWM.

Genet Med. 2018 Jan;20(1):109-118. doi: 10.1038/gim.2017.74. Epub 2017 Jul 20.

PMID:
28726805
7.

Annealing of Au, Ag and Au-Ag alloy nanoparticle arrays on GaAs (100) and (111)B.

Whiticar AM, Mårtensson EK, Nygård J, Dick KA, Bolinsson J.

Nanotechnology. 2017 May 19;28(20):205702. doi: 10.1088/1361-6528/aa6aef.

PMID:
28445163
8.

Demonstration of Sn-seeded GaSb homo- and GaAs-GaSb heterostructural nanowires.

Tornberg M, Mårtensson EK, Zamani RR, Lehmann S, Dick KA, Ghalamestani SG.

Nanotechnology. 2016 Apr 29;27(17):175602. doi: 10.1088/0957-4484/27/17/175602. Epub 2016 Mar 17.

PMID:
26984940
9.

Comprehensive genetic analysis of a paediatric pleomorphic myxoid liposarcoma reveals near-haploidization and loss of the RB1 gene.

Hofvander J, Jo VY, Ghanei I, Gisselsson D, Mårtensson E, Mertens F.

Histopathology. 2016 Jul;69(1):141-147. doi: 10.1111/his.12913. Epub 2016 Feb 9.

PMID:
26647907
10.

Seawater mesocosm experiments in the Arctic uncover differential transfer of marine bacteria to aerosols.

Fahlgren C, Gómez-Consarnau L, Zábori J, Lindh MV, Krejci R, Mårtensson EM, Nilsson D, Pinhassi J.

Environ Microbiol Rep. 2015 Jun;7(3):460-70. doi: 10.1111/1758-2229.12273. Epub 2015 Apr 6.

PMID:
25682947
11.

Ecohydrological responses to diversion of groundwater: case study of a deep-rock repository for spent nuclear fuel in Sweden.

Werner K, Collinder P, Berglund S, Mårtensson E.

Ambio. 2013 May;42(4):517-26. doi: 10.1007/s13280-013-0404-8.

12.

The prevalence of peripheral neuropathy in a population-based study of patients with type 2 diabetes in Sweden.

Kärvestedt L, Mårtensson E, Grill V, Elofsson S, von Wendt G, Hamsten A, Brismar K.

J Diabetes Complications. 2011 Mar-Apr;25(2):97-106. doi: 10.1016/j.jdiacomp.2010.04.001. Epub 2010 May 21.

PMID:
20488731
13.

Peripheral sensory neuropathy associates with micro- or macroangiopathy: results from a population-based study of type 2 diabetic patients in Sweden.

Kärvestedt L, Mårtensson E, Grill V, Elofsson S, von Wendt G, Hamsten A, Brismar K.

Diabetes Care. 2009 Feb;32(2):317-22. doi: 10.2337/dc08-1250. Epub 2008 Nov 25.

14.

Caries-preventive effect of an oral health program for preschool children in a low socio-economic, multicultural area in Sweden: results after one year.

Wennhall I, Mårtensson EM, Sjunnesson I, Matsson L, Schröder U, Twetman S.

Acta Odontol Scand. 2005 Jun;63(3):163-7.

PMID:
16191910
15.
16.

Subcellular targeting analysis of SDR-type hydroxysteroid dehydrogenases.

Filling C, Wu X, Shafqat N, Hult M, Mårtensson E, Shafqat J, Oppermann UC.

Mol Cell Endocrinol. 2001 Jan 22;171(1-2):99-101.

PMID:
11165017
17.

Type 1 11beta -hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets.

Davani B, Khan A, Hult M, Mårtensson E, Okret S, Efendic S, Jörnvall H, Oppermann UC.

J Biol Chem. 2000 Nov 10;275(45):34841-4.

19.

Characterization of MK-801-induced behavior as a putative rat model of psychosis.

Andiné P, Widermark N, Axelsson R, Nyberg G, Olofsson U, Mårtensson E, Sandberg M.

J Pharmacol Exp Ther. 1999 Sep;290(3):1393-408.

PMID:
10454519
20.

Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans.

Hartigan-Go K, Bateman DN, Nyberg G, Mårtensson E, Thomas SH.

Clin Pharmacol Ther. 1996 Nov;60(5):543-53.

PMID:
8941027
21.

A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients.

Dencker SJ, Giös I, Mårtensson E, Nordén T, Nyberg G, Persson R, Roman G, Stockman O, Svärd KO.

Psychopharmacology (Berl). 1994 Feb;114(1):24-30.

PMID:
7846204
22.

Amitriptyline and amitriptyline metabolites in blood and cerebrospinal fluid following human overdose.

Hultén BA, Heath A, Knudsen K, Nyberg G, Svensson C, Mårtensson E.

J Toxicol Clin Toxicol. 1992;30(2):181-201.

PMID:
1588668
23.

Severe amitriptyline overdose: relationship between toxicokinetics and toxicodynamics.

Hultén BA, Heath A, Knudsen K, Nyberg G, Starmark JE, Mårtensson E.

J Toxicol Clin Toxicol. 1992;30(2):171-9.

PMID:
1588667
24.

Determination of the serum concentrations of thioridazine and its main metabolites using a solid-phase extraction technique and high-performance liquid chromatography.

Svensson C, Nyberg G, Soomägi M, Mårtensson E.

J Chromatogr. 1990 Jul 13;529(1):229-36. No abstract available.

PMID:
2211938
25.

Active metabolites of neuroleptics in plasma and CSF: implications for therapeutic drug monitoring.

Mårtensson E, Nyberg G.

Psychopharmacol Ser. 1989;7:257-62. Review. No abstract available.

PMID:
2574451
26.
27.

Clinical and metabolic features of ethanol-methanol poisoning in chronic alcoholics.

Martensson E, Olofsson U, Heath A.

Lancet. 1988 Feb 13;1(8581):327-8.

PMID:
2893139
29.
31.

Concentrations of thioridazine and thioridazine metabolites in erythrocytes.

Svensson C, Nyberg G, Axelsson R, Mårtensson E.

Psychopharmacology (Berl). 1986;89(3):291-2.

PMID:
3088651
32.

Thioridazine toxicity--an experimental cardiovascular study of thioridazine and its major metabolites in overdose.

Heath A, Svensson C, Mårtensson E.

Vet Hum Toxicol. 1985 Apr;27(2):100-5.

PMID:
3992882
33.

Determination of free fractions of tricyclic antidepressants.

Nyberg G, Mårtensson E.

Naunyn Schmiedebergs Arch Pharmacol. 1984 Sep;327(3):260-5.

PMID:
6493364
34.

Lidocaine and amitriptyline interaction during experimental haemoperfusion.

Heath A, Löfström B, Mårtensson E.

Hum Toxicol. 1984 Jun;3(3):165-71.

PMID:
6745959
35.

Treatment of antidepressant poisoning with resin hemoperfusion.

Heath A, Wickström I, Mårtensson E, Ahlmén J.

Hum Toxicol. 1982 Oct;1(4):361-71.

PMID:
7173920
36.

Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism.

Axelsson R, Mårtensson E, Alling C.

Eur J Clin Pharmacol. 1982 Oct;23(4):359-63.

PMID:
7173306
37.

Impairment of the blood-brain barrier as an aetiological factor in paranoid psychosis.

Axelsson R, Martensson E, Alling C.

Br J Psychiatry. 1982 Sep;141:273-81.

PMID:
7139211
38.

Binding of thioridazine and thioridazine metabolites to serum proteins. An in vitro study.

Nyberg G, Mårtensson E.

Naunyn Schmiedebergs Arch Pharmacol. 1982 Jun;319(3):189-96.

PMID:
7110380
39.

Cerebrospinal fluid concentrations of thioridazine and its main metabolites in psychiatric patients.

Nyberg G, Axelsson R, Mårtensson E.

Eur J Clin Pharmacol. 1981 Jan;19(2):139-48. No abstract available.

PMID:
7202474
40.

Hemoperfusion with Amberlite resin in the treatment of self-poisoning.

Heath A, Delin K, Edén E, Mårtensson E, Selander D, Wickström I, Ahlmén J.

Acta Med Scand. 1980;207(6):455-60.

PMID:
7424564
41.

Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients.

Nyberg G, Axelsson R, Mårtensson E.

Eur J Clin Pharmacol. 1978 Dec 18;14(5):341-50. No abstract available.

PMID:
32045
42.

Quantitative analysis of tricyclic antidepressants in serum from psychiatric patients.

Nyberg G, Mårtensson E.

J Chromatogr. 1977 Sep 1;143(5):491-7.

PMID:
561116
43.

Serum concentration and elimination from serum of thioridazine in psychiatric patients.

Axelsson R, Mårtensson E.

Curr Ther Res Clin Exp. 1976 Feb;19(2):242-65. No abstract available.

PMID:
813963
44.

Quantitative determination of thioridazine and nonconjugated thioridazine metabolites in serum and urine of psychiatric patients.

Mårtensson E, Nyberg G, Axelsson R, Serck-Hansen K.

Curr Ther Res Clin Exp. 1975 Nov;18(5):687-700. No abstract available.

PMID:
812647
45.

[Aging and the psychological functions].

Mårtensson E.

Lakartidningen. 1975 Jul 23;72(30-31):2954-5. Swedish. No abstract available.

PMID:
1142948
46.

Galactosyltransferases catalyzing the formation of the galactosyl-galactosyl linkage in glycosphingolipids.

Mårtensson E, Ohman R, Graves M, Svennerholm L.

J Biol Chem. 1974 Jul 10;249(13):4132-7. No abstract available.

47.

A gas chromatographic method for determining haloperidol. A sensitive procedure for studying serum concentration and pharmacokinetics of haloperidol in patients.

Forsman A, Mårtensson E, Nyberg G, Ohman R.

Naunyn Schmiedebergs Arch Pharmacol. 1974;286(2):113-24. No abstract available.

PMID:
4281877
48.

Serum levels of thioridazine in psychiatric patients and healthy volunteers.

Mårtensson E, Roos BE.

Eur J Clin Pharmacol. 1973 Oct;6(3):181-6. No abstract available.

PMID:
4762056
49.

[Bromine abuse--still a reality].

Axelsson R, Forsman A, Mårtensson E, Selerud A.

Lakartidningen. 1972 Aug 2;69(32):3636-40. Swedish. No abstract available.

PMID:
5070376
50.

Pathologic lysosomes and increased urinary glycosylceramide excretion in Fabry's disease. Studies on a family with evidence of linkage with the sex-linked blood group Xg.

Malmqvist E, Ivemark BI, Lindsten J, Maunsbach AB, Mårtensson E.

Lab Invest. 1971 Jul;25(1):1-14. No abstract available.

PMID:
4326523

Supplemental Content

Loading ...
Support Center